Obesity is a raging conversation globally now, and manufacturing of generics will pick up after the patent expires.' ...
4h
TheHealthSite.com on MSNDelhi Battles Worst Swine Flu Outbreak In Years: 54% Households Report Severe COVID-Like Symptoms, Viral FeverSurvey shows 54% household has 1 patient suffering from swine flu symptoms, such as fever, sore throat, cough, headache, ...
Discover protective tips to lower lung cancer risk even with a smoking history. Proven approaches for current and former ...
Chronic obstructive pulmonary disease (COPD) is among the most common breathing conditions. It's the result of damaged lung ...
The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...
18h
News Medical on MSNNew drug VIP36 shows promise in treating pain without harmful side effectsA research team funded by the National Institutes of Health (NIH) has developed a medication that shows promise in treating acute and chronic pain.
Jazz Pharmaceuticals plc is buying Chimerix Inc. for $8.55 a share in cash, bringing the deal in at about $935 million. Jazz expands its cancer pipeline with the new acquisition’s lead candidate, ...
Chimerix is currently awaiting an FDA decision on accelerated approval of a drug it’s developing for a type of glioma.
Q. I woke up a few weeks ago unable to catch my breath. It is a scary feeling, and I was freaked out. Fortunately, my wife had an albuterol inhaler handy that she uses for asthma. That seemed to solve ...
Amgen Inc. (NASDAQ:AMGN) 45th Annual TD Cowen Health Care Conference Transcript March 5, 2025 9:10 AM ETCompany ParticipantsJay Bradner - Executive ...
20h
MedPage Today on MSNFirst Generics for Low-Dose Rivaroxaban Get FDA ApprovalThe FDA approved the first generics of the direct oral anticoagulant rivaroxaban, the agency announced on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results